Universtiy of Vermont is a clinical research site located in Burlington, Vermont, United States 05405.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Universtiy of Vermont has participated in 1 clinical trials.
Therapeutic areas: Recurrent Platinum Resistant Ovarian Cancer.
Sponsors: Vascular Biogenics Ltd. operating as VBL Therapeutics.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Universtiy of Vermont has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Universtiy of Vermont has 1 clinical trials on record. Their work covers Recurrent Platinum Resistant Ovarian Cancer.
Universtiy of Vermont has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.